9.212
Bearbeitungen
Änderungen
Zur Navigation springen
Zur Suche springen
Die Seite wurde neu angelegt: „{{NYT en}} <!-- right|thumb| --> Apligraf is a synthetic skin created from harvested foreskins.<ref>{{REFweb |quote=Human keratino…“
{{NYT en}}
<!-- [[Image:Alloderm-logo.jpg|right|thumb|]] -->
Apligraf is a synthetic skin created from harvested foreskins.<ref>{{REFweb
|quote=Human keratinocytes and fibroblasts are derived from neonatal foreskins
|url=http://www.apligraf.com/professional/what_is_apligraf/how_is_it_made/
|title=Apligraf: How Is It Made?
|last=
|first=
|publisher=Organogenesis
|date=
|accessdate=2011-03-06
}}</ref> It is [[FDA]] approved,<ref>{{REFweb
|quote=Apligraf® is the first bio-engineered cell based product to receive FDA approval (in 1998).
|url=http://www.organogenesis.com/products/bioactive_woundhealing/apligraf.html
|title=Apligraf
|last=
|first=
|publisher=Organogenesis
|date=
|accessdate=2011-03-06
}}</ref> and it is made and sold by [[Organogenesis]], which a corporation based in Canton, MA. Novartis Pharmaceuticals Corp. has global marketing rights to Apligraf.
== Apligraph Oral ==
Organogenesis is presently seeking FDA approval for Apligraph Oral, a foreskin-derived product for the "treatment of surgically treated gingival and alveolar mucosal surface defects in adults."<ref>{{REFnews
|last=
|first=
|url=http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/BloodVaccinesandOtherBiologics/CellularTissueandGeneTherapiesAdvisoryCommittee/UCM284112.pdf
|format=PDF
|title=November 17, 2011: Cellular, Tissue and Gene Therapies Advisory Committee Meeting: Transcript
|date=2011-11-17
|publisher=FDA
|quote=
|accessdate=2011-12-20
}}</ref>
Sponsor slides: http://www.fda.gov/downloads/advisorycommittees/committeesmeetingmaterials/bloodvaccinesandotherbiologics/cellulartissueandgenetherapiesadvisorycommittee/ucm284480.pdf
{{REF}}
[[Kategorie:Vorhaut-Produkte]]
[[Kategorie:Finanzieller Vorteil]]
[[Kategorie:Von CircLeaks]]
[[Kategorie:Von IntactWiki]]
[[en:{{FULLPAGENAME}}]]
<!-- [[Image:Alloderm-logo.jpg|right|thumb|]] -->
Apligraf is a synthetic skin created from harvested foreskins.<ref>{{REFweb
|quote=Human keratinocytes and fibroblasts are derived from neonatal foreskins
|url=http://www.apligraf.com/professional/what_is_apligraf/how_is_it_made/
|title=Apligraf: How Is It Made?
|last=
|first=
|publisher=Organogenesis
|date=
|accessdate=2011-03-06
}}</ref> It is [[FDA]] approved,<ref>{{REFweb
|quote=Apligraf® is the first bio-engineered cell based product to receive FDA approval (in 1998).
|url=http://www.organogenesis.com/products/bioactive_woundhealing/apligraf.html
|title=Apligraf
|last=
|first=
|publisher=Organogenesis
|date=
|accessdate=2011-03-06
}}</ref> and it is made and sold by [[Organogenesis]], which a corporation based in Canton, MA. Novartis Pharmaceuticals Corp. has global marketing rights to Apligraf.
== Apligraph Oral ==
Organogenesis is presently seeking FDA approval for Apligraph Oral, a foreskin-derived product for the "treatment of surgically treated gingival and alveolar mucosal surface defects in adults."<ref>{{REFnews
|last=
|first=
|url=http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/BloodVaccinesandOtherBiologics/CellularTissueandGeneTherapiesAdvisoryCommittee/UCM284112.pdf
|format=PDF
|title=November 17, 2011: Cellular, Tissue and Gene Therapies Advisory Committee Meeting: Transcript
|date=2011-11-17
|publisher=FDA
|quote=
|accessdate=2011-12-20
}}</ref>
Sponsor slides: http://www.fda.gov/downloads/advisorycommittees/committeesmeetingmaterials/bloodvaccinesandotherbiologics/cellulartissueandgenetherapiesadvisorycommittee/ucm284480.pdf
{{REF}}
[[Kategorie:Vorhaut-Produkte]]
[[Kategorie:Finanzieller Vorteil]]
[[Kategorie:Von CircLeaks]]
[[Kategorie:Von IntactWiki]]
[[en:{{FULLPAGENAME}}]]